High Blood Pressure

Clinical Trial Finder

Many patients with high blood pressure are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases

Condition:   Pulmonary Hypertension
Intervention:  
Sponsor:   Silesian Centre for Heart Diseases
Recruiting - verified May 2016

Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: Nebulized ipratropium bromide;   Drug: Nebulized combination ipratropium bromide with salbutamol;   Drug: Nebulized Placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified May 2016

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure

Conditions:   Pulmonary Hypertension;   Mirabegron;   Heart Failure;   Pulmonary Vascular Resistance Abnormality
Interventions:   Drug: Mirabegron;   Drug: Placebo
Sponsors:   Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III;   Hospital Clinic of Barcelona;   Hospital Universitario 12 de Octubre;   Puerta de Hierro University Hospital;   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Not yet recruiting - verified May 2016

Text Messages and Blood Pressure Control

Condition:   Hypertension
Intervention:   Other: Bi-directional texting
Sponsor:   University of Iowa
Recruiting - verified May 2016

Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)

Condition:   Pulmonary Hypertension
Intervention:  
Sponsor:   Cairo University
Not yet recruiting - verified May 2016

Bidirectional Text Messaging for Measurement and Motivation of Medication Adherence in Hypertension, a Pilot Study

Condition:   Hypertension
Interventions:   Behavioral: Electronic Pill Bottle;   Behavioral: Bidirectional Text Messaging
Sponsor:   University of Pennsylvania
Not yet recruiting - verified May 2016

Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR

Conditions:   Pulmonary Hypertension;   Chronic Obstructive Lung Disease
Intervention:  
Sponsor:   Cairo University
Not yet recruiting - verified May 2016

Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers

Conditions:   Preeclampsia;   Hypertension;   Proteinuria;   Thrombocytopenia;   Renal Insufficiency;   Impaired Liver Function;   Pulmonary Edema
Intervention:  
Sponsor:   Progenity, Inc.
Recruiting - verified May 2016

Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome

Condition:   Metabolic Syndrome
Interventions:   Drug: Metformin;   Dietary Supplement: Agave inulin;   Other: Placebo of agave inulin;   Other: Metformin placebo
Sponsor:   Centro Universitario de Ciencias de la Salud, Mexico
Completed - verified May 2016

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

Conditions:   Hypertension;   Cholesterolemia
Interventions:   Drug: DP-R208;   Drug: Candesartan32mg;   Drug: Rosuvastatin 20mg;   Drug: DP-R208 Placebo;   Drug: Candesartan32mg Placebo;   Drug: Rosuvastatin 20mg Placebo
Sponsor:   Alvogen Korea
Recruiting - verified May 2016

ConfidenHT System for Diagnostic Electrical Mapping of Renal Nerves

Condition:   Hypertension
Intervention:   Device: ConfidenHT system
Sponsor:   Pythagoras Medical
Not yet recruiting - verified May 2016

Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients

Conditions:   Connective Tissue Diseases;   Pulmonary Hypertension
Intervention:  
Sponsor:   Cairo University
Not yet recruiting - verified May 2016

CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs

Condition:   Drug-Related Side Effects and Adverse Reactions
Interventions:   Drug: Diclofenac;   Other: Placebo
Sponsor:   Eduardo Barbosa Coelho
Completed - verified May 2016

The Treatment of Hepatocirrhosis and Portal Hypertension

Condition:   Hepatic Cirrhosis
Intervention:   Procedure: PSE
Sponsors:   Yanjing Gao;   Shandong Provincial Hospital;   Jinan Military General Hospital
Recruiting - verified May 2016

A Physical Activity Program in Liver Wait List Candidates

Conditions:   End-stage Liver Disease (ESLD);   Liver Transplant;   Sarcopenia;   Poor Physical Fitness;   Cirrhosis;   Portal Hypertension
Interventions:   Other: Nutritional consultation;   Behavioral: Physical training program;   Behavioral: Behavioral modification therapy
Sponsor:   University of Arkansas
Not yet recruiting - verified May 2016

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

Condition:   Colorectal Neoplasms
Interventions:   Drug: BI 695502;   Drug: chemotherapy
Sponsor:   Boehringer Ingelheim
Not yet recruiting - verified May 2016

Development and Evaluation of the ICP Waveform Tracing Capabilities and Safety of HS-1000 Device

Conditions:   Brain Injuries;   Intracranial Hypertension
Intervention:   Device: HS-1000
Sponsors:   HeadSense Medical;   Oslo University Hospital
Completed - verified May 2016

An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device

Conditions:   Intracranial Hypertension;   Brain Injuries;   Stroke;   Hydrocephalus;   Brain Neoplasms
Intervention:   Device: HS-1000
Sponsor:   HeadSense Medical
Recruiting - verified May 2016

Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP Monitoring

Conditions:   Brain Injuries;   Intracranial Hypertension
Intervention:   Device: HS-1000
Sponsors:   HeadSense Medical;   Elisabeth-TweeSteden Ziekenhuis
Completed - verified May 2016

Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement

Condition:   Intracranial Hypertension
Intervention:   Device: HS-1000
Sponsors:   HeadSense Medical;   Rigshospitalet, Denmark
Recruiting - verified May 2016

Comparing Different Methods of Patient Education on Preeclampsia

Conditions:   Preeclampsia;   Anxiety;   Hypertension;   Pregnancy;   Eclampsia;   HELLP
Interventions:   Other: Graphic card;   Other: Video
Sponsor:   Geisinger Clinic
Recruiting - verified April 2016

Epidemiology of Risk Factors for Hospital-acquired Pneumonia (HAP) in Intensive Care Unit (ICU) Patients

Condition:   Ventilator-Associated Pneumonia
Intervention:   Other: Epidemiology od HAP
Sponsor:   University Hospital Olomouc
Completed - verified May 2016

A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Adempas (Riociguat, BAY63-2521)
Sponsor:   Bayer
Not yet recruiting - verified May 2016

Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome

Condition:   Metabolic Syndrome
Interventions:   Drug: Metformin;   Dietary Supplement: Agave inulin;   Other: Placebo of agave inulin;   Other: Metformin placebo
Sponsor:   Centro Universitario de Ciencias de la Salud, Mexico
Completed - verified May 2016

Effects of Preoperative Fasting on ECG and Vital Parameters

Conditions:   Fasting;   Intraoperative Complications;   Ischemia
Interventions:   Other: Preoperative Fasting for 8 hours;   Other: Preoperative Fasting for more than 12 hours;   Drug: Spinal Anesthesia with Bupivacaine
Sponsor:   Bozyaka Training and Research Hospital
Not yet recruiting - verified May 2016

Pressure Difference Between Brain and Eye: a Possible Cause to Normal Tension Glaucoma.

Condition:   Normal Tension Glaucoma
Intervention:  
Sponsors:   Umeå University;   Västerbotten County Council, Sweden
Recruiting - verified May 2016

Effect of a Female Strength & Conditioning Specialist on High School Girls' Health

Conditions:   Physical Inactivity;   Low Physical Fitness
Intervention:   Other: Girls-only resistance training
Sponsor:   University of Manitoba
Not yet recruiting - verified May 2016

The Church as a Bridge to Deliver Health Resources Via Telehealth

Conditions:   Obesity;   Diet, Food, and Nutrition;   Church;   Healthcare Disparities;   Minority Health;   Mobile Health;   Telehealth;   Community-based Participatory Research;   Primary Health Care;   Weight Loss Programs;   Health Behavior
Intervention:   Behavioral: Church Bridge Project
Sponsors:   University of Southern Mississippi;   Southeast Mississippi Rural Health Initiative;   MSU Extension- Stone County
Not yet recruiting - verified May 2016

Comparison Between Standard and Ultrasound Integrated Approach for Risk Stratification of Syncope in the Emergency Department

Condition:   Syncope
Intervention:  
Sponsor:   University of Turin, Italy
Recruiting - verified May 2016

Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine

Condition:   Endometrial Cancer
Intervention:  
Sponsors:   Centre Hospitalier Universitaire de Nice;   Centre National de la Recherche Scientifique, France
Not yet recruiting - verified May 2016

Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication

Condition:   Glaucoma
Interventions:   Drug: Prostaglandin analogue;   Procedure: Selective laser trabeculoplasy;   Device: laser
Sponsors:   University College, London;   University of KwaZulu;   Kisii Eye Hospital Kisii Kenya
Recruiting - verified May 2016

Impact of Ageing on Adipose, Muscle and Systemic Inflammation

Conditions:   Inflammation;   Aging
Intervention:   Other: Maintaining a normal daily living lifestyle
Sponsor:   University of Bath
Recruiting - verified May 2016

Aging, Nitrate, Endothelial Function and Muscle Oxygenation

Conditions:   Aging;   Hypertension;   Dyslipidemia;   Abdominal Obesity
Interventions:   Other: Beetroot-based nutritional gel;   Other: Placebo
Sponsors:   Universidade Federal do Rio de Janeiro;   Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Completed - verified May 2016

Cerebral and Spinal Protection of Xenon Post-conditioning in Patients Undergoing Aortic Dissection Repair

Condition:   Aortic Dissection
Intervention:   Drug: xenon
Sponsor:   Beijing Anzhen Hospital
Active, not recruiting - verified May 2016

A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma

Conditions:   Ocular Hypertension;   Open-Angle Glaucoma
Interventions:   Drug: MGV354 ophthalmic suspension;   Drug: MGV354 placebo
Sponsors:   Alcon Research;   Novartis Institute for BioMedical Research
Recruiting - verified May 2016

The Precision Hypertension Care Study

Condition:   Hypertension
Interventions:   Drug: Zestril®;   Drug: Atacand®;   Drug: Norvasc®;   Drug: Hydrochlorthiazide®;   Drug: Treatment X;   Drug: Treatment Y;   Drug: Placebo
Sponsor:   Uppsala University
Not yet recruiting - verified May 2016

Omics Signature in the Diagnosis of Hypertension

Condition:   Hypertension
Intervention:   Other: omics
Sponsors:   Radboud University;   European Union
Not yet recruiting - verified April 2016

A Cohort Study of Operationally Tolerant Allograft Recipients

Conditions:   Kidney Transplant;   Liver Transplant
Intervention:   Procedure: Blood Draw
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN)
Not yet recruiting - verified May 2016

Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors

Conditions:   Neuroendocrine Tumors;   Gastro Entero Pancreatic Neuroendocrine Tumors
Interventions:   Drug: 28 GBq 177Lu-DOTATATE;   Drug: 22 GBq 177Lu-DOTATATE
Sponsors:   Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori;   Istituto Europeo di Oncologia IEO MILANO
Recruiting - verified May 2016

Yoga as a Supportive Therapy for Patients With Hypertension

Condition:   Hypertension
Interventions:   Behavioral: Yoga with Asana (yoga postures);   Behavioral: Yoga without Asana (yoga postures)
Sponsor:   Universität Duisburg-Essen
Recruiting - verified May 2016

Application Contract Management Mode in Maintaining PD Fluid Balance

Condition:   Contract Management PD
Intervention:   Behavioral: Contract management
Sponsor:   The Second Affiliated Hospital of Harbin Medical University
Not yet recruiting - verified May 2016

Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection

Condition:   Hepatocellular Carcinoma
Interventions:   Drug: Oxaliplatin(OXA), 5-fluorouracil (5-FU);   Procedure: Hepatic arterial catheter implantation
Sponsor:   Beijing Cancer Hospital
Recruiting - verified May 2016

Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide

Condition:   Hypertension
Interventions:   Drug: Nebivolol;   Drug: Hydrochlorothiazide
Sponsor:   University of California, San Diego
Completed - verified May 2016

Arterial Stiffness as a Predictor of Response to Renal Sympathetic Denervation

Condition:   Therapy Resistant Arterial Hypertension
Intervention:   Device: Renal sympathetic denervation (RDN)
Sponsor:   University of Leipzig
Recruiting - verified May 2016

Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients

Conditions:   Cardiovascular Diseases;   Diabetes Mellitus;   Medication Adherence
Intervention:   Behavioral: Pharmacist-led, technology enabled education intervention
Sponsors:   Medical University of South Carolina;   National Institutes of Health (NIH)
Recruiting - verified April 2016

Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases

Conditions:   Diabetes Mellitus, Type 2;   Metabolic Syndrome X;   Hypertension;   Cardiovascular Diseases;   Stroke
Intervention:   Other: Fructose-containing Sugars
Sponsors:   University of Toronto;   Canadian Institutes of Health Research (CIHR);   The Physicians' Services Incorporated Foundation;   Canadian Diabetes Association (CDA)
Active, not recruiting - verified May 2016

Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension

Condition:   Pulmonary Hypertension
Intervention:   Device: Exhaled Breath Olfactory Signature (Artificial Nose)
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Technion, Israel Institute of Technology;   Bayer
Recruiting - verified March 2016

Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: FLOLAN injection with currently marketed diluent;   Drug: FLOLAN injection with reformulated diluent
Sponsor:   GlaxoSmithKline
Not yet recruiting - verified March 2016

Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors

Conditions:   Dyslipidemia;   Diabetes;   Prediabetes;   Dysglycemia;   Gout;   Hypertension;   Non-alcoholic Fatty Liver Disease;   Cardiovascular Disease
Intervention:   Other: Fructose-containing Sugars
Sponsors:   University of Toronto;   Canadian Diabetes Association (CDA);   The Physicians' Services Incorporated Foundation;   Banting and Best Diabetes Centre (BBDC)
Active, not recruiting - verified May 2016

Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk

Conditions:   Obesity;   Dyslipidemia;   Prediabetes;   Dysglycemia;   Gout;   Hypertension;   Non-Alcoholic Fatty Liver Disease;   Cardiovascular Disease
Interventions:   Other: High Fructose Corn Syrup;   Other: Sucrose
Sponsors:   University of Toronto;   Canadian Institutes of Health Research (CIHR);   The Physicians' Services Incorporated Foundation;   Banting and Best Diabetes Centre (BBDC)
Active, not recruiting - verified May 2016

Non-invasive Intracranial Pressure (ICP) Monitoring in Pediatric Patients

Condition:   Intracranial Hypertension
Intervention:   Device: HS-1000 recording
Sponsors:   HeadSense Medical;   Akron Children's Hospital
Not yet recruiting - verified May 2016

WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)

Conditions:   Williams Syndrome;   Cardiovascular Disease;   Multisystem Developmental Disorder;   Elastin Gene Deletion;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2016

Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia

Condition:   Preeclampsia
Intervention:   Other: Testing for antiphospholipid antibodies
Sponsor:   Mohamed Sayed Abdelhafez
Recruiting - verified May 2016

Efficacy of Sildenafil in Preterm Preeclampsia

Condition:   Preterm Preeclampsia
Interventions:   Drug: Sildenafil;   Drug: Placebo
Sponsor:   The University of Texas Health Science Center, Houston
Not yet recruiting - verified May 2016

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: iNO 15 mcg/kg IBW/hr;   Drug: iNO 75 mcg/kg IBW/hr;   Drug: Placebo Dose setting of 15 mcg/kg IBW/hr;   Drug: Placebo Dose setting of 75 mcg/kg IBW/hr
Sponsor:   Bellerophon Pulse Technologies
Recruiting - verified May 2016

A Study of the ReCor Medical Paradise System in Clinical Hypertension

Conditions:   Hypertension;   Vascular Diseases
Interventions:   Device: The Paradise® Renal Denervation Ultrasound System;   Device: Sham Procedure
Sponsor:   ReCor Medical, Inc.
Recruiting - verified March 2016

An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

Conditions:   Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Intervention:   Drug: Inhaled Treprostinil
Sponsor:   United Therapeutics
Enrolling by invitation - verified May 2016

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Conditions:   Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Interventions:   Drug: Inhaled Treprostinil;   Drug: Placebo
Sponsor:   United Therapeutics
Recruiting - verified May 2016

Text Messaging to Promote Walking Among Latino Adults at Risk for Peripheral Arterial Disease

Condition:   Peripheral Arterial Disease
Interventions:   Other: Text Messages;   Other: Phone Calls;   Other: Handout
Sponsors:   University of Kansas Medical Center;   National Institute on Aging (NIA)
Recruiting - verified May 2016

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

Conditions:   Breast Carcinoma;   Hypertension
Intervention:   Other: Laboratory Biomarker Analysis
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified May 2016

Nesiritide in Uncontrolled Hypertension

Condition:   Hypertension
Interventions:   Drug: Nesiritide;   Drug: Placebo
Sponsors:   Oslo University Hospital;   University of Oslo;   University Hospital, Akershus
Recruiting - verified December 2015

Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults

Conditions:   Acute Kidney Injury;   Chronic Kidney Disease;   Hypertension
Interventions:   Drug: Iodohippurate;   Procedure: 24 hour ambulatory Blood Pressure;   Procedure: Peripheral Arterial Tonometry;   Procedure: Pulse Wave Velocity;   Drug: Gadolinium
Sponsor:   University of Florida
Recruiting - verified May 2016

Severe Sepsis in Children - IMPRESS-C

Conditions:   Acute Kidney Injury;   Chronic Kidney Disease;   Hypertension
Interventions:   Drug: Iodohippurate;   Procedure: 24 hour ambulatory Blood Pressure;   Procedure: Peripheral Arterial Tonometry;   Procedure: Pulse Wave Velocity;   Drug: Gadolinium
Sponsor:   University of Florida
Not yet recruiting - verified May 2016

Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Intervention:   Behavioral: Rehabilitation
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Recruiting - verified May 2016

Sympathetic and Blood Pressure Responses to Aerobic Exercise and Guided Respiration in Hypertensives

Condition:   Hypertension
Interventions:   Device: Resperate®-InterCure Ltda;   Other: Music group (GC);   Device: Portable radio
Sponsor:   University of Sao Paulo General Hospital
Completed - verified May 2016

OTIS - Optimized Complementary Feeding Study

Conditions:   Infant Development;   Body Composition, Beneficial;   Dietary Modification
Interventions:   Other: Systematic introduction of taste portions;   Other: Protein reduced complementary foods;   Other: Nordic diet
Sponsors:   Umeå University;   Semper AB;   University of California;   MRC Human Nutrition Research
Recruiting - verified May 2016

Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Conditions:   Open-angle Glaucoma;   Ocular Hypertension
Interventions:   Drug: PG324 Ophthalmic Solution;   Drug: Netarsudil (AR-13324) Ophthalmic Solution;   Drug: Latanoprost Ophthalmic Solution
Sponsor:   Aerie Pharmaceuticals
Active, not recruiting - verified May 2016

A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat (Adempas, BAY63-2521)
Sponsor:   Bayer
Recruiting - verified May 2016

Egypt Hypertension Study

Condition:   Different Classes of the Antihypertensive Treatment.
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified May 2016

Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C

Condition:   Hepatitis C
Interventions:   Procedure: Functional Hepatic Nitrogen Clearance (FHNC);   Procedure: Galactose Elimination Capacity (GEC);   Procedure: Liver vein catheterization
Sponsors:   University of Aarhus;   Aarhus University Hospital;   AbbVie
Recruiting - verified May 2016

Intestinal Phosphate Transporter Expression in CKD Patients

Condition:   Chronic Kidney Diseases
Intervention:   Procedure: endoscopy
Sponsors:   RWTH Aachen University;   Chugai Pharmaceutical
Recruiting - verified May 2016

Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Conditions:   Glaucoma, Open-Angle;   Ocular Hypertension
Interventions:   Drug: Bimatoprost SR;   Other: Sham Bimatoprost SR;   Procedure: Selective Laser Trabeculoplasty;   Other: Sham Selective Laser Trabeculoplasty
Sponsor:   Allergan
Recruiting - verified May 2016

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity

Conditions:   Posttraumatic Stress Disorder;   Depression;   Alcohol-Related Disorders;   Suicidal Ideation;   Substance-Related Disorders;   Mild Cognitive Impairment;   Quality of Life;   Pain;   Wounds and Injury;   Brain Injuries;   Chronic Disease
Interventions:   Behavioral: Motivational Interviewing;   Behavioral: Cognitive Behavioral Therapy Elements;   Behavioral: Care Management;   Drug: Fluoxetine;   Drug: Fluvoxamine;   Drug: Paroxetine;   Drug: Setraline;   Drug: Citalopram;   Drug: Venlafaxine;   Drug: Duloxetine;   Drug: Mirtazapine;   Drug: Diphenhydramine;   Drug: Trazodone;   Drug: Prazosin
Sponsors:   University of Washington;   National Institutes of Health (NIH)
Recruiting - verified May 2016

Bridging Income Generation With Group Integrated Care

Conditions:   Cardiovascular Disease;   Diabetes
Interventions:   Other: Usual Clinical Care;   Other: Group Medical Visits;   Other: Microfinance Groups
Sponsors:   Icahn School of Medicine at Mount Sinai;   Moi University College of Health Sciences;   Brown University;   Duke University;   Purdue University;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified May 2016

TAK-491 (Azilsartan Medoxomil) Compared to Valsartan in Chinese Participants With Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Azilsartan medoxomil;   Drug: Valsartan;   Drug: Azilsartan medoxomil Placebo;   Drug: Valsartan Placebo
Sponsor:   Takeda
Recruiting - verified May 2016

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

Condition:   Hypertension, Portal
Interventions:   Drug: GR-MD-02;   Drug: Placebo
Sponsors:   Galectin Therapeutics Inc.;   Brooke Army Medical Center, Stephen A. Harrison, MD;   Indiana University, Naga Chalasani, MD
Recruiting - verified March 2016

Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation

Conditions:   Video-assisted Thoracoscopic Surgery;   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Inhaled iloprost;   Drug: normal saline (Saline 0.9%)
Sponsor:   Yonsei University
Recruiting - verified May 2016

RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure

Condition:   Participants With the MTHFR 677TT Genotype
Interventions:   Dietary Supplement: Placebo comparator;   Dietary Supplement: 1.6mg riboflavin (Vitamin B2);   Dietary Supplement: 10mg riboflavin (Vitamin B2)
Sponsors:   University of Ulster;   DSM Nutritional Products, Inc.
Active, not recruiting - verified May 2016

Promoting Self-Management in Low Income African Americans Living With Hypertension

Condition:   Hypertension
Intervention:   Behavioral: Ecological Nurse Case Management
Sponsors:   Bev Zabler;   Medical College of Wisconsin
Completed - verified May 2016

Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT

Condition:   ESRD
Intervention:   Dietary Supplement: Sodium Restriction
Sponsors:   University of Pennsylvania;   National Institute of Nursing Research (NINR)
Active, not recruiting - verified May 2016

Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages

Condition:   Medication Non-adherence
Intervention:   Behavioral: SMS (Text messages)
Sponsors:   University of Michigan;   Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified May 2016

Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae

Condition:   Arteriovenous Fistula
Interventions:   Device: Lutonix DCB;   Device: Standard Balloon Angioplasty Catheter
Sponsor:   C. R. Bard
Active, not recruiting - verified May 2016

Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat (ADEMPAS, BAY63-2521)
Sponsor:   Bayer
Recruiting - verified May 2016

Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients

Condition:   Sedation in Intensive Care
Interventions:   Drug: Clonidine;   Drug: Midazolam
Sponsors:   University of Erlangen-Nürnberg Medical School;   Erasmus Medical Center;   University of Tartu;   Therakind Ltd;   Gianni Benzi Pharmacological Research Foundation;   University College, London;   Karolinska Institutet;   Univerzita Karlova v Praze;   Vereniging Samenwerkende Ouder- En Patientenorganisaties;   Bambino Gesù Hospital and Research Institute;   European Commission
Active, not recruiting - verified May 2016

The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension

Condition:   Essential Hypertension
Interventions:   Other: 20% ethanol;   Other: Homoeopathic complex
Sponsor:   University of Johannesburg
Completed - verified May 2016

Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml

Conditions:   Ocular Hypertension;   Glaucoma
Interventions:   Drug: Preserved Bimatoprost 0.01%;   Drug: Tafluprost Unit Dose Preservative Free 15microgram/ml
Sponsors:   Universitaire Ziekenhuizen Leuven;   Allergan
Recruiting - verified May 2016

Ventricular Reversed Remodeling After LTX in PAH Patients

Condition:   Pulmonary Arterial Hypertension
Intervention:  
Sponsors:   University Medical Center Groningen;   VU University Medical Center
Enrolling by invitation - verified May 2016

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

Condition:   Essential Hypertension With Stable Angina and Dyslipidemia
Intervention:   Drug: Azilsartan
Sponsor:   Takeda
Withdrawn - verified May 2016

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

Condition:   Glaucoma, Neovascular
Interventions:   Drug: Aflibercept (Eylea, BAY 86-5321);   Drug: Sham Injection
Sponsors:   Bayer;   Regeneron Pharmaceuticals
Recruiting - verified May 2016

Effects of Tart Cherry and Aroniaberry Supplementation on Endothelial Function and Cardiovascular Measures in Healthy Older Adults: Interactions With Genotype and Proteome

Conditions:   Cardiovascular Disease;   Coronary Heart Disease;   Aging
Intervention:  
Sponsor:   National Institute of Nursing Research (NINR)
Recruiting - verified May 2016

Doxazosin for PTSD and Alcohol Use Disorder

Conditions:   PTSD;   Alcohol Use Disorder
Interventions:   Drug: Doxazosin;   Drug: Placebo
Sponsors:   Medical University of South Carolina;   Ralph H. Johnson VA Medical Center
Not yet recruiting - verified May 2016

The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study

Condition:   Preeclampsia
Intervention:  
Sponsor:   University of Pennsylvania
Recruiting - verified May 2016

Eplerenone in Heart Failure Treatment

Conditions:   Heart Failure;   Acute Myocardial Infarction;   Hypertension
Intervention:  
Sponsor:   Elpen Pharmaceutical Co. Inc.
Completed - verified May 2016

Pilot Study of of Renal Arterial Sympathetic Denervation by Cryotherapy

Condition:   Hypertension
Intervention:   Procedure: Cryo-therapy
Sponsor:   University Hospital, Linkoeping
Active, not recruiting - verified May 2016

Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

Conditions:   End Stage Renal Disease;   Vascular Access Patency
Interventions:   Drug: ticagrelor;   Drug: Placebo
Sponsors:   University of Virginia;   AstraZeneca
Recruiting - verified May 2016

Effects of Ketamine in the Acute Phase of Suicidal Ideation

Condition:   Suicidal Ideation
Interventions:   Other: Baseline evaluation;   Drug: 1st perfusion of ketamine;   Drug: 1st perfusion of saline;   Other: Follow-up between perfusions;   Drug: 2nd perfusion of ketamine;   Drug: 2nd perfusion of saline;   Other: Follow-up after perfusions
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Recruiting - verified May 2016

Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone

Conditions:   Alcoholic Hepatitis;   Alcoholic Liver Disease
Interventions:   Drug: Amoxicillin;   Drug: Placebo;   Drug: Prednisolone
Sponsors:   University Hospital, Lille;   Ministry of Health, France
Recruiting - verified May 2016

A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Out Comes?

Condition:   Physician Education
Intervention:   Drug: Regorafenib (Stivarga, BAY 73-4506)
Sponsor:   Bayer
Terminated - verified May 2016

ENDOBARRIER® and Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients

Condition:   Metabolic Syndrome
Intervention:   Device: ENDOBARRIER®
Sponsors:   University Hospital, Lille;   Ministry of Health, France
Suspended - verified May 2016

GS-4997 in Adults With Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: GS-4997;   Drug: Placebo to match GS-4997
Sponsor:   Gilead Sciences
Active, not recruiting - verified May 2016

Evaluation of Quality of Care - Multi-disciplinary Risk Assessment and Management Programme for Patients With Hypertension, HA (QoC RAMP-HT)

Condition:   Hypertension
Intervention:  
Sponsors:   The University of Hong Kong;   Hospital Authority, Hong Kong
Recruiting - verified May 2016

Study 3: Minocycline Decreases Microglia Activation

Condition:   Hypertension
Intervention:   Other: Minocycline
Sponsors:   University of Florida;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified May 2016

Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

Condition:   Preeclampsia
Intervention:   Drug: Oxytocin
Sponsor:   University of Colorado, Denver
Recruiting - verified May 2016

AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.

Condition:   Polycythemia Vera
Intervention:   Drug: Pegylated-Proline-interferon alpha-2b
Sponsors:   AOP Orphan Pharmaceuticals AG;   PharmaEssentia (Co-Sponsor for USA)
Recruiting - verified May 2016

The Role of Gut Microbiota in Hypertension

Condition:   Hypertension
Intervention:   Other: Stool Sample and Blood Sample
Sponsor:   University of Florida
Recruiting - verified May 2016

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

Conditions:   Diabetes Mellitus, Type 2;   Hypertension
Interventions:   Drug: Empagliflizon low dose;   Drug: placebo;   Drug: Empagliflizon high dose
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Recruiting - verified May 2016

Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial

Condition:   Atherosclerosis
Interventions:   Drug: Eplerenone;   Drug: Placebo
Sponsor:   University of Maryland
Recruiting - verified May 2016

Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

Condition:   the Maintenance Phase After Kidney Transplantation
Intervention:   Drug: Graceptor®
Sponsor:   Astellas Pharma Inc
Completed - verified May 2016

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

Conditions:   Hypertension;   Cardiac Arrhythmias;   Diabetes Mellitus;   Renal Insufficiency;   Sleep Apnea
Intervention:  
Sponsor:   Elpen Pharmaceutical Co. Inc.
Recruiting - verified May 2016

Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Minocycline 100mg Group;   Drug: Minocycline 200mg Group
Sponsors:   University of Florida;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 2016

Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Minocycline Group;   Other: Placebo Group
Sponsors:   University of Florida;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified May 2016

Controlled Education Of Patients After Stroke

Conditions:   Stroke;   Hypertension
Intervention:   Other: optimised follow-up
Sponsors:   University Hospital, Lille;   Ministry of Health, France
Recruiting - verified May 2016

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat (ADEMPAS, BAY63-2521)
Sponsor:   Bayer
Recruiting - verified May 2016

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Condition:   Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions:   Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
Sponsor:   Bayer
Terminated - verified May 2016

Treatment of Atrial Fibrillation in Patients by Pulmonary Vein Isolation in Combination With Renal Denervation or Pulmonary Vein Isolation Only

Conditions:   Paroxysmal Atrial Fibrillation;   Persistent Atrial Fibrillation;   Out of Range Hypertension;   Signs of Sympathetic Overdrive
Intervention:   Procedure: procedure
Sponsor:   Diagram B.V.
Recruiting - verified May 2016

Prematurity as Predictor of Children's Cardiovascular-renal Health

Conditions:   Endothelial Dysfunction;   Sublingual Capillary Glycocalyx and Density;   Visual Disturbances and Blindness;   Ventricular Dysfunction, Left;   Renal Impairment
Intervention:  
Sponsor:   Universitaire Ziekenhuizen Leuven
Completed - verified November 2015

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat(BAY63-2521)
Sponsor:   Bayer
Recruiting - verified May 2016

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Condition:   Carotid Stenosis
Interventions:   Procedure: Carotid endarterectomy;   Device: Carotid stenting
Sponsors:   Thomas G. Brott, M.D.;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified May 2016

Conditioned Pharmacotherapeutic Effects in Hypertension

Condition:   Hypertension
Intervention:   Drug: carvedilol
Sponsor:   University of Rochester
Recruiting - verified May 2016

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Conditions:   Hypertension;   Cardiovascular Disease
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified March 2016

UAB Center of Research Translation (CORT) Project 2: The Effects of Urate Lowing Therapy (ULT) in Inflammation, Endothelial Function, and Blood Pressure

Conditions:   Pre-hypertension;   JNC 7 Stage I Hypertension
Interventions:   Drug: Allopurinol;   Drug: Placebo
Sponsors:   University of Alabama at Birmingham;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2016

The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease

Conditions:   Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Interstitial Pneumonitis;   Desquamative Interstitial Pneumonia
Interventions:   Other: Aerobic Exercise Training;   Other: Education
Sponsors:   National Institutes of Health Clinical Center (CC);   George Mason University;   Inova Fairfax Hospital
Recruiting - verified March 2016

PC Protocol: Preconceptional Screening

Condition:   Infertility
Intervention:  
Sponsor:   UMC Utrecht
Recruiting - verified May 2016

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

Condition:   Complicated Urinary Tract Infections (cUTI)
Interventions:   Drug: Eravacycline;   Drug: Levofloxacin
Sponsor:   Tetraphase Pharmaceuticals, Inc.
Active, not recruiting - verified May 2016

Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery

Conditions:   Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Intervention:   Drug: IK-3001
Sponsor:   Mallinckrodt
Completed - verified May 2016

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Iloprost (Ventavis, BAYQ6256)
Sponsor:   Bayer
Recruiting - verified May 2016

Evaluation of Quality of Care - Patient Empowerment Programme, HA

Conditions:   Diabetes Mellitus;   Hypertension
Intervention:  
Sponsors:   The University of Hong Kong;   Hospital Authority, Hong Kong
Recruiting - verified May 2016

Beraprost-314d Added-on to Tyvaso® (BEAT)

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
Sponsor:   Lung Biotechnology PBC
Recruiting - verified March 2016

Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study

Conditions:   Sleep Disordered Breathing;   Obstructive Sleep Apnea;   Adenotonsillectomy;   Snoring;   Obstructive Sleep Disordered Breathing
Intervention:   Procedure: Adenotonsillectomy (AT)
Sponsors:   Chania General Hospital ”St. George”;   Aghia Sophia Children's Hospital of Athens
Active, not recruiting - verified May 2016

Community Level Interventions for Pre-eclampsia

Conditions:   Pre-eclampsia;   Hypertension, Pregnancy Induced
Interventions:   Behavioral: Community Engagement;   Device: PIERS on the Move mHealth decision aid;   Drug: Magnesium Sulfate;   Drug: Methyldopa
Sponsors:   University of British Columbia;   Bill and Melinda Gates Foundation;   Olabisi Onabanjo University;   Centro de Investigacao em Saude de Manhica;   Aga Khan University;   Jawaharlal Nehru Medical College
Recruiting - verified May 2016

The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular Health

Conditions:   Preeclampsia;   Preterm Birth
Intervention:  
Sponsors:   University of Oxford;   British Heart Foundation
Recruiting - verified May 2016

Self-Management and Educational Support in Extremely Obese Patients Awaiting Bariatric Care

Condition:   Obesity
Intervention:   Behavioral: Weight Wise Community Modules
Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR);   Alberta Innovates Health Solutions;   Alberta Health Services
Completed - verified May 2016

Resveratrol and Cardiovascular Health in the Elderly

Conditions:   Vascular Resistance;   Aging;   Hypertension;   Antioxidants;   Aerobic Capacity
Interventions:   Dietary Supplement: Resveratrol;   Drug: Placebo
Sponsor:   National Institute on Aging (NIA)
Recruiting - verified April 2016

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Condition:   Hypertension, Pulmonary
Interventions:   Drug: Tadalafil;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified May 2016

Hormonal, Metabolic, and Signaling Interactions in PAH

Conditions:   Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:  
Sponsor:   Vanderbilt University
Recruiting - verified May 2016

Renal Denervation in Treatment Resistant Hypertension

Condition:   Hypertension
Interventions:   Procedure: Ablation of the renal arteries;   Procedure: Renal angiography
Sponsors:   Henrik Vase;   Aarhus University Hospital;   Regionshospitalet Silkeborg;   Randers Regional Hospital;   Central Jutland Regional Hospital;   Regional Hospital Holstebro
Terminated - verified May 2016

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Macitentan 10 mg tablet, once daily.
Sponsor:   Actelion
Enrolling by invitation - verified May 2016

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

Conditions:   Pulmonary Disease;   Pulmonary Hypertension
Intervention:  
Sponsor:   National Institutes of Health Clinical Center (CC)
Recruiting - verified April 2016

Spironolactone for Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: Spironolactone;   Drug: Placebo
Sponsors:   National Institutes of Health Clinical Center (CC);   National Heart, Lung, and Blood Institute (NHLBI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Pennsylvania;   University of Maryland;   Washington Hospital Center;   New England Medical Center, Tufts University School of Medicine
Recruiting - verified April 2016

A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Condition:   Pulmonary Hypertension, Familial Persistent, of the Newborn
Interventions:   Drug: placebo;   Drug: iv sildenafil
Sponsor:   Pfizer
Recruiting - verified May 2016

Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.

Conditions:   Turner Syndrome;   Aortic Aneurysm;   Ischemic Heart Disease;   Hypertension;   Congenital Heart Defect
Intervention:  
Sponsor:   University of Aarhus
Active, not recruiting - verified June 2015

X-chromosome Inactivation, Epigenetics and the Transcriptome

Conditions:   Turner Syndrome;   Klinefelter Syndrome;   Triple X Syndrome;   47 XYY Syndrome;   Aortic Aneurysm
Intervention:  
Sponsors:   University of Aarhus;   Lundbeck Foundation;   The Korning Foundation Denmark;   AP Moeller Foundation
Completed - verified June 2015

Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

Condition:   Hypertension
Interventions:   Drug: Take ACE-I;   Drug: Hold ACE-I
Sponsor:   University of Nebraska
Enrolling by invitation - verified May 2016

Glaucoma Biomarkers

Conditions:   Glaucoma;   Healthy
Intervention:   Drug: Variation in eye pressure response to timolol and latanoprost treatment
Sponsors:   University of Michigan;   University of Nebraska;   Mayo Clinic;   National Eye Institute (NEI)
Active, not recruiting - verified May 2016

Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors

Condition:   Hypertension, Resistant to Conventional Therapy
Intervention:   Procedure: Renal sympathetic denervation
Sponsors:   University Hospital of North Norway;   University of Tromso;   The Royal Norwegian Ministry of Health;   Odd Berg Medical research Foundation
Completed - verified May 2016

Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension

Conditions:   Pulmonary Arterial Hypertension;   Hypertension, Pulmonary
Intervention:   Drug: Sildenafil
Sponsor:   Pfizer
Recruiting - verified May 2016

Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease

Conditions:   Overweight;   Obesity;   Dyslipidemia;   Hyperlipidemia;   Diabetes;   Prediabetes;   Dysglycemia;   Gout;   Hypertension;   Metabolic Syndrome;   Coronary Heart Disease;   Cardiovascular Disease
Intervention:  
Sponsors:   John Sievenpiper;   Calorie Control Council;   Canada Research Chairs Endowment of the Federal Government of Canada;   Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified May 2016

Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome

Conditions:   Metabolic Syndrome;   Dyslipidemia;   Hypertriglyceridemia
Interventions:   Other: Standard reference diet;   Other: Almond supplemented diet;   Other: Low carbohydrate reference diet
Sponsors:   Children's Hospital & Research Center Oakland;   Almond Board of California
Active, not recruiting - verified November 2015

Blood Vessel Study

Condition:   Endothelial Cell Function
Intervention:  
Sponsor:   National Institute of Environmental Health Sciences (NIEHS)
Enrolling by invitation - verified February 2016

Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease

Conditions:   Alzheimer's Disease;   Cardiovascular Risk Factors
Interventions:   Other: optimal care of VRF;   Other: standard care
Sponsors:   University Hospital, Lille;   Ministry of Health, France
Recruiting - verified May 2016

Mifepristone for Metabolic Syndrome

Conditions:   Endocrine Disease;   Diabetes
Intervention:   Drug: Mifepristone
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2016

Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation

Condition:   Acute Respiratory Distress Syndrome
Interventions:   Procedure: Surfactant instillation;   Procedure: nCPAP
Sponsor:   Centre Hospitalier Universitaire, Amiens
Terminated - verified May 2016

Real-time MRI Right Heart Catheterization Using Passive Catheters

Conditions:   Caridovascular Disease;   Congenital Heart Disease;   Pulmonary Hypertension
Interventions:   Device: Balloon catheter for right heart catheterization;   Drug: Gadopentate Dimeglumine (Gadolinium); Contrast Agent;   Procedure: Right Heart Catheterization;   Procedure: Cardiac Real-time MRI;   Procedure: Vascular Hemostasis
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2016

Long-Term Non-Interventional Latanoprost Study

Conditions:   Glaucoma;   Ocular Hypertension
Interventions:   Other: No intervention other than routine medical care;   Other: No intervention other than routine medical care
Sponsor:   Pfizer
Completed - verified May 2016

Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial

Condition:   Portopulmonary Hypertension
Intervention:   Drug: Ambrisentan
Sponsors:   Tufts Medical Center;   Gilead Sciences
Active, not recruiting - verified May 2016

Early Primary Prophylaxis of Esophageal Varices

Condition:   Cirrhosis
Interventions:   Drug: Carvedilol;   Drug: Placebo
Sponsor:   Institute of Liver and Biliary Sciences, India
Completed - verified December 2013

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Condition:   Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions:   Biological: Rituximab;   Other: Placebo
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2016

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis

Conditions:   Systemic Sclerosis;   Scleroderma
Intervention:   Drug: Ambrisentan
Sponsors:   University of Pennsylvania;   Gilead Sciences
Active, not recruiting - verified May 2016

Reduction of the Metabolic Syndrome in Navarra-Spain

Conditions:   Metabolic Syndrome;   Obesity;   Diabetes;   Cardiovascular Disease
Interventions:   Behavioral: Crononutrition;   Behavioral: American Heart Association
Sponsors:   Clinica Universidad de Navarra, Universidad de Navarra;   Hospital of Navarra
Completed - verified November 2011

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Conditions:   Acne Vulgaris;   Allergic Rhinitis;   Anxiety;   Asthma;   Back Pain;   Prostatic Hyperplasia;   Bursitis;   Chronic Obstructive Pulmonary Disease;   Cough;   Coronary Artery Disease;   Depression;   Diabetes Mellitus;   Diarrhea;   Gastroesophageal Reflux;   Fibromyalgia;   Headache;   HIV Infections;   Hypothyroidism;   Hyperlipidemia;   Hypertension;   Influenza;   Sleep Initiation and Maintenance Disorders;   Irritable Bowel Syndrome;   Knee Pain;   Migraine Disorders;   Obesity;   Obstructive Sleep Apnea;   Osteoarthritis;   Senile Osteoporosis;   Colonoscopy;   Mammography;   Shoulder Pain;   Sinusitis;   Smoking Cessation;   Tobacco Use Cessation;   Menopause;   Urinary Incontinence;   Urinary Tract Infection;   Vaccination;   Vaginitis;   Vertigo
Intervention:   Other: health information prescription
Sponsors:   University of Missouri-Columbia;   National Library of Medicine (NLM)
Completed - verified March 2011

The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension

Condition:   Hypertension
Interventions:   Dietary Supplement: grape seed extract;   Dietary Supplement: grape seed extract placebo
Sponsors:   Institute for Food Safety and Health, United States;   Polyphenolics, Inc.
Active, not recruiting - verified May 2016

Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure

Condition:   Hypoxic Respiratory Failure With Pulmonary Hypertension
Interventions:   Drug: Inhaled Nitric Oxide;   Drug: Placebo
Sponsor:   Mallinckrodt
Withdrawn - verified May 2016

BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension

Condition:   Pulmonary Hypertension
Intervention:   Drug: Riociguat (Adempas, BAY63-2521)
Sponsor:   Bayer
Active, not recruiting - verified May 2016

SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

Conditions:   Scleroderma, Systemic;   Sclerosis
Intervention:   Drug: currently available therapy in the community
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified May 2016

Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy

Conditions:   Hypertension;   Diabetes
Intervention:   Device: In-home "smart" diagnostic devices
Sponsors:   University of Missouri-Columbia;   Agency for Healthcare Research and Quality (AHRQ)
Completed - verified August 2011

Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)

Condition:   Hypertension, Pulmonary
Intervention:   Drug: Riociguat (Adempas, BAY63-2521)
Sponsor:   Bayer
Active, not recruiting - verified May 2016

Medication Adherence in Hypertension Study

Condition:   Hypertension
Intervention:   Behavioral: Feedback-based behavioral medication adherence intervention
Sponsors:   University of Missouri-Columbia;   The John A. Hartford Foundation
Completed - verified May 2016

Aerobic Exercise in Patients With Pulmonary Hypertension

Condition:   Hypertension, Pulmonary
Interventions:   Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
Sponsors:   National Institutes of Health Clinical Center (CC);   George Mason University;   Inova Fairfax Hospital
Completed - verified May 2016

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

Conditions:   Allergic Rhinitis;   Asthma;   Back Pain;   Benign Prostatic Hypertrophy;   Bursitis;   Depression;   Anxiety;   Diabetes Mellitus;   Esophageal Reflux;   HIV Infections;   Hyperlipidemia;   Hypertension;   Insomnia;   Irritable Bowel Syndrome;   Obesity;   Osteoporosis (Senile);   Shoulder Pain;   Sinusitis;   Symptomatic Menopause;   Urinary Incontinence;   Urinary Tract Infection;   Vaginitis
Intervention:   Other: Health Information Prescription - MedlinePlus link
Sponsors:   University of Missouri-Columbia;   National Library of Medicine (NLM)
Completed - verified March 2011

Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome

Condition:   Chronic Fatigue Syndrome
Interventions:   Drug: Placebo;   Drug: Sodium Oxybate
Sponsors:   University of Medicine and Dentistry of New Jersey;   Jazz Pharmaceuticals
Terminated - verified February 2016

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

Condition:   Cerebrovascular Accident
Intervention:   Other: No intervention
Sponsors:   University of Rostock;   Shire Human Genetic Therapies, Inc.
Completed - verified May 2016

Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

Condition:   Hypertension
Intervention:   Drug: MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified May 2016

Diagnostic Performance of Screening Tests for Cushing s Syndrome

Condition:   Cushing's Syndrome
Intervention:  
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting - verified February 2016

Hyzaar Asia HEAALTH (0954A-950)

Condition:   Hypertension
Intervention:   Drug: losartan potassium (+) hydrochlorothiazide
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified May 2016

Bosentan in Children With Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Bosentan
Sponsor:   Actelion
Completed - verified May 2016

A Prospective Study of Living Kidney Donation

Condition:   Living Kidney Donors
Intervention:  
Sponsors:   Amit Garg;   Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified May 2016

Reference Values for Plasma Catechols

Conditions:   Healthy Volunteers;   Normal Physiology
Intervention:  
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified May 2016

Scleroderma: Cyclophosphamide or Transplantation (SCOT)

Conditions:   Scleroderma, Systemic;   Sclerosis;   Autoimmune Disease
Interventions:   Procedure: Autologous stem cell transplantation;   Drug: Cyclophosphamide;   Drug: Antithymocyte globulin, equine;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Radiation: Total body irradiation (TBI)
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified May 2016

Natural History of Sickle Cell Disease and Other Hemolytic Disorders

Conditions:   Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2016

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Conditions:   Pulmonary Hypertension;   Sickle Cell Anemia;   Sickle Cell Disease
Intervention:  
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified April 2016

Sodium Transport: Genetics and Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2001

Epidemic Hypertension in Nigerian Workers

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Eclampsia;   Pre-Eclampsia
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified March 2005

High Blood Pressure in the Young

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Job Strain, Ambulatory Blood Pressure and Hypertension

Conditions:   Cardiovascular Diseases;   Cerebrovascular Accident;   Hypertension;   Heart Diseases
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Socioeconomic Status, John Henryism and Hypertension Risk in Blacks

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension

Conditions:   Cardiovascular Diseases;   Hypertension;   Heart Diseases
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Risk Factors for Pulmonary Hypertension of the Newborn

Conditions:   Persistent Fetal Circulation Syndrome;   Lung Diseases
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified October 2005

DISH Data Analysis Study

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Ambulatory Blood Pressure and Behavior

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2000

Ambulatory Blood Pressure and Prognosis

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2000

Muscatine Heart Study

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Hypertension;   Heart Diseases
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified July 2000

Insulin Resistance and Blood Pressure Regulation in Blacks

Conditions:   Cardiovascular Diseases;   Hypertension;   Heart Diseases;   Insulin Resistance
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified June 2000

Epidemiology of Carotid Disease in Elderly Adults

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Carotid Artery Diseases;   Atherosclerosis
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified December 2004

Minneapolis Children's Blood Pressure Study

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Obesity
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified June 2000

Racial Differences in the Coronary Microcirculation

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Hypertension;   Myocardial Ischemia;   Hypertrophy, Left Ventricular
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified July 2000

Lipoprotein Metabolism in Hypertensive African-Americans

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hyperinsulinism;   Hypertension;   Insulin Resistance
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified June 2001

Suppressed Anger, Blood Pressure and Mortality Follow-up

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Renin and Prorenin in Pregnancy

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Pregnancy Toxemias;   Pre-Eclampsia
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Kidney Failure, Chronic
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified March 2005

Primary Prevention of CHD Risk Factors Occurring in US

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Coronary Heart Disease Risk Reduction;   Coronary Disease;   Hypertension;   Hypercholesterolemia
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified November 2002

Precursors of CVD Risk Factors--Project Heartbeat

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypercholesterolemia;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified March 2004

Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Kidney Failure, Chronic
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Insulin, Androgen, and Risk in African-American Women

Conditions:   Cardiovascular Diseases;   Diabetes Mellitus;   Hypertension;   Heart Diseases;   Hyperinsulinism;   Insulin Resistance
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified March 2005

Framingham Cycle V Offspring-Spouse Nutrition Studies

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Hypertension;   Obesity;   Diabetes Mellitus;   Atherosclerosis
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Mechanisms Underlying Abnormal Ambulatory BP Patterns

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified November 2001

Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Myocardial Diseases;   Asthma;   Diabetes Mellitus;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Epidemiology of Blood Pressure, Insulin, Salt Transport

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Obesity
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2000

Patterns of Fatty Acids in Framingham Offspring

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Atherosclerosis
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified July 2002

Exercise and Blood Pressure in Children: A Meta-Analysis

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified December 2004

Decline in Cardiovascular Mortality: Framingham 1950-1984

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Hypertension;   Heart Diseases
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2000

Survival After Myocardial Infarction in A Biethnic Texas Community (Corpus Christi Heart Project)

Conditions:   Cardiovascular Diseases;   Hypertension;   Coronary Disease;   Myocardial Infarction
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2001

Immunogenetic Factors of Coronary Heart Disease

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Hypertension;   Obesity;   Diabetes Mellitus;   Hypothyroidism
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2000

Sleep Apnea in a Non-Clinical Population

Conditions:   Lung Diseases;   Sleep Apnea Syndromes;   Obesity;   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Framingham Nutrition Studies

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Blood Pressure Control--Racial and Psychosocial Influences

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2006

Diagnosis of Pheochromocytoma

Condition:   Pheochromocytoma
Intervention:  
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2016

Treatment of Hypertension With Two Exercise Intensities

Condition:   Hypertension
Intervention:   Behavioral: exercise
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified August 2004

Oral Calcium in Pregnant Women With Hypertension

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Pre-Eclampsia;   Pregnancy Toxemias;   Vascular Diseases
Interventions:   Behavioral: dietary supplements;   Drug: calcium
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2002

Metabolic Differences of Overweight Children and Children of Overweight Parents

Condition:   Obesity
Intervention:  
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting - verified March 2016

Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause

Conditions:   Cardiovascular Diseases;   Diabetes Mellitus;   Heart Diseases;   Hypercholesterolemia;   Hypertension;   Obesity;   Menopause;   Postmenopause
Intervention:   Behavioral: diet, fat-restricted
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2002

Postmenopausal Estrogen/Progestin Interventions (PEPI)

Conditions:   Bone Diseases;   Cardiovascular Diseases;   Coronary Disease;   Diabetes Mellitus;   Heart Diseases;   Hypercholesterolemia;   Hypertension;   Myocardial Ischemia;   Osteoporosis;   Thrombosis;   Postmenopause
Interventions:   Drug: estrogens, conjugated;   Drug: medroxyprogesterone;   Drug: progesterone;   Drug: estrogen replacement therapy
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Institute on Aging (NIA);   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed - verified July 2005